Association between age and infection in patients with acute ST-elevation myocardial infarction
1Department of Cardiovascular Medicine, Assiut University Heart Hospital, Assiut University, Asyut, 71515, Egypt. magdyalgowhary@aun.edu.eg.
Background:
ST-elevation myocardial infarction (STEMI) in young patients has a unique risk profile. We aimed to detect bacteria in aspirate of infarct artery in young versus old patients.
Results:
Aspirates of consecutive 140 patients who underwent a primary coronary intervention were taken for bacteriological, microscopical, and immunohistochemical (for bacterial pneumolysin) examinations. Their results were calculated in young (≤ 50 years) versus old (> 50 years) patients. Median age (interquartile range) was 45 (38-48) years in young (60 patients) and 59 (55-65) years in old (80 patients) patients, p < 0.0001. Both groups had similar baseline data except age, males, diabetes, hyperlipidemia, family history, lesion length, and ectatic vessel. Different bacteria were cultured in 11.3% of all patients involving 22.6% of young and 2.8% of old patients [hazard ratio 8.03 (95% CI 1.83-51.49), p = 0.002]. By multivariate analyses, age groups and leukocytic count were independent predictors of infection (bacteria and pneumolysin), p = 0.027 and p < 0.0001, respectively. Optimal cutoff value of leukocytic count was 12,250 cells/μl [ROC curve sensitivity 85.7%, specificity 86.4%, and AUC 0.97 (95% CI 0.95-1.0), p < 0.001]. Infection was an independent predictor of STEMI in young versus old patients, p < 0.001. Nevertheless, in-hospital events occurred insignificantly different and neither age groups nor infection was predictor of in-hospital events.
Conclusions:
Young patients had significantly higher percentage of bacteria in their infarcted artery than old patients. High leukocytic count in patients below 50 predicts infection that causes acute myocardial infarction. Antibacterial trials directed toward this group are required for secondary prevention.
Insights
Young patients with ST-elevation myocardial infarction (STEMI) show higher rates of bacterial infection in their arteries. High white blood cell counts can predict this infection, suggesting a need for antibacterial treatments in younger individuals.
Area of Science:
- Cardiology
- Infectious Diseases
- Microbiology
Background:
- ST-elevation myocardial infarction (STEMI) presents unique challenges in younger populations.
- Investigating the role of bacterial presence in the infarct artery of young vs. old STEMI patients is crucial.
Purpose of the Study:
- To determine the prevalence of bacteria in the infarct artery of young (≤50 years) and old (>50 years) STEMI patients.
- To identify predictors of infection and its association with STEMI in different age groups.
Main Methods:
- Bacteriological, microscopical, and immunohistochemical analyses of infarct artery aspirates from 140 STEMI patients undergoing primary coronary intervention.
- Comparison of bacterial detection rates and clinical outcomes between young and old patient cohorts.
- Multivariate analysis to identify independent predictors of infection and STEMI.
Main Results:
- Bacteria were detected in 22.6% of young STEMI patients compared to 2.8% of old patients (p=0.002).
- Elevated leukocytic count (≥12,250 cells/μl) was an independent predictor of infection (sensitivity 85.7%, specificity 86.4%).
- Infection was an independent predictor of STEMI in young patients (p<0.001), but in-hospital events did not differ significantly between groups.
Conclusions:
- Young STEMI patients exhibit a significantly higher incidence of bacterial presence in the infarct artery.
- High leukocytic count is a strong indicator of infection in younger patients with acute myocardial infarction.
- Further research and antibacterial interventions are warranted for secondary prevention in this demographic.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis I: Introduction
